Full Text View
Tabular View
No Study Results Posted
Related Studies
Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization
This study has been completed.
Study NCT00479895   Information provided by Biopure Corporation
First Received: May 25, 2007   Last Updated: May 29, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Occlusion
Acute Coronary Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Coronary Disease
Disease
Heart Diseases
Myocardial Ischemia
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
HBOC 201
More general drug interventions related to this trial
Blood Substitutes
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Biopure Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services